TY - STD TI - Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Jama. 2002, 288: 2981-2997. 10.1001/jama.288.23.2981. ID - ref1 ER - TY - JOUR AU - Hiramatsu, K. AU - Yamada, T. AU - Yukimura, Y. AU - Komiya, I. AU - Ichikawa, K. AU - Ishihara, M. AU - Nagata, H. AU - Izumiyama, T. PY - 1981 DA - 1981// TI - A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients JO - Arch Intern Med VL - 141 UR - https://doi.org/10.1001/archinte.1981.00340130033011 DO - 10.1001/archinte.1981.00340130033011 ID - Hiramatsu1981 ER - TY - JOUR AU - Gordon, R. D. PY - 1994 DA - 1994// TI - Mineralocorticoid hypertension JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)93003-1 DO - 10.1016/S0140-6736(94)93003-1 ID - Gordon1994 ER - TY - JOUR AU - Lim, P. O. AU - Dow, E. AU - Brennan, G. AU - Jung, R. T. AU - MacDonald, T. M. PY - 2000 DA - 2000// TI - High prevalence of primary aldosteronism in the Tayside hypertension clinic population JO - J Hum Hypertens VL - 14 UR - https://doi.org/10.1038/sj.jhh.1001013 DO - 10.1038/sj.jhh.1001013 ID - Lim2000 ER - TY - JOUR AU - Lim, P. O. AU - Rodgers, P. AU - Cardale, K. AU - Watson, A. D. AU - MacDonald, T. M. PY - 1999 DA - 1999// TI - Potentially high prevalence of primary aldosteronism in a primary-care population JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(05)74868-6 DO - 10.1016/S0140-6736(05)74868-6 ID - Lim1999 ER - TY - JOUR AU - Lim, P. O. AU - Macdonald, T. M. AU - Holloway, C. AU - Friel, E. AU - Anderson, N. H. AU - Dow, E. AU - Jung, R. T. AU - Davies, E. AU - Fraser, R. AU - Connell, J. M. PY - 2002 DA - 2002// TI - Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio JO - J Clin Endocrinol Metab VL - 87 UR - https://doi.org/10.1210/jc.2001-012070 DO - 10.1210/jc.2001-012070 ID - Lim2002 ER - TY - JOUR AU - Lim, P. O. AU - Farquharson, C. A. AU - Shiels, P. AU - Jung, R. T. AU - Struthers, A. D. AU - MacDonald, T. M. PY - 2001 DA - 2001// TI - Adverse cardiac effects of salt with fludrocortisone in hypertension JO - Hypertension VL - 37 UR - https://doi.org/10.1161/01.HYP.37.3.856 DO - 10.1161/01.HYP.37.3.856 ID - Lim2001 ER - TY - CHAP AU - Young, W. PY - 1999 DA - 1999// BT - Incidence and workup of primary aldosteronism at the Mayo Clinic: ; Brisbane. ID - Young1999 ER - TY - CHAP AU - Gordon, R. PY - 1999 DA - 1999// BT - Incidence and workup of primary aldosteronism: Greenslopes Hospital series: ; Brisbane. ID - Gordon1999 ER - TY - CHAP AU - Van Heerden J A, A. F. C. PY - 1999 DA - 1999// BT - Outcomes of surgery for primary aldosteronism: an instituinal experience: ; Brisbane. ID - Van Heerden J A1999 ER - TY - JOUR AU - Brown, J. J. AU - Davies, D. L. AU - Ferriss, J. B. AU - Fraser, R. AU - Haywood, E. AU - Lever, A. F. AU - Robertson, J. I. PY - 1972 DA - 1972// TI - Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin JO - Br Med J VL - 2 UR - https://doi.org/10.1136/bmj.2.5816.729 DO - 10.1136/bmj.2.5816.729 ID - Brown1972 ER - TY - JOUR AU - Ghose, R. P. AU - Hall, P. M. AU - Bravo, E. L. PY - 1999 DA - 1999// TI - Medical management of aldosterone-producing adenomas JO - Ann Intern Med VL - 131 UR - https://doi.org/10.7326/0003-4819-131-2-199907200-00005 DO - 10.7326/0003-4819-131-2-199907200-00005 ID - Ghose1999 ER - TY - JOUR AU - Lim, P. O. AU - Young, W. F. AU - MacDonald, T. M. PY - 2001 DA - 2001// TI - A review of the medical treatment of primary aldosteronism JO - J Hypertens VL - 19 UR - https://doi.org/10.1097/00004872-200103000-00001 DO - 10.1097/00004872-200103000-00001 ID - Lim2001 ER - TY - JOUR AU - Adlin, E. V. AU - Marks, A. D. AU - Channick, B. J. PY - 1972 DA - 1972// TI - Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity JO - Arch Intern Med VL - 130 UR - https://doi.org/10.1001/archinte.1972.03650060047008 DO - 10.1001/archinte.1972.03650060047008 ID - Adlin1972 ER - TY - JOUR AU - Gwinup, G. AU - Steinberg, T. PY - 1967 DA - 1967// TI - Differential response to thiazides and spironolactone in primary aldosteronism JO - Arch Intern Med VL - 120 UR - https://doi.org/10.1001/archinte.1967.04410010050007 DO - 10.1001/archinte.1967.04410010050007 ID - Gwinup1967 ER - TY - JOUR AU - Lim, P. O. AU - Jung, R. T. AU - MacDonald, T. M. PY - 1999 DA - 1999// TI - Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study JO - Br J Clin Pharmacol VL - 48 UR - https://doi.org/10.1046/j.1365-2125.1999.00070.x DO - 10.1046/j.1365-2125.1999.00070.x ID - Lim1999 ER - TY - JOUR AU - Gallay, B. J. AU - Ahmad, S. AU - Xu, L. AU - Toivola, B. AU - Davidson, R. C. PY - 2001 DA - 2001// TI - Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio JO - Am J Kidney Dis VL - 37 UR - https://doi.org/10.1016/S0272-6386(01)80117-7 DO - 10.1016/S0272-6386(01)80117-7 ID - Gallay2001 ER - TY - JOUR AU - O'Brien, E. AU - Waeber, B. AU - Parati, G. AU - Staessen, J. AU - Myers, M. G. PY - 2001 DA - 2001// TI - Blood pressure measuring devices: recommendations of the European Society of Hypertension JO - Bmj VL - 322 UR - https://doi.org/10.1136/bmj.322.7285.531 DO - 10.1136/bmj.322.7285.531 ID - O'Brien2001 ER - TY - JOUR AU - Suwaidi, J. A. AU - Hamasaki, S. AU - Higano, S. T. AU - Nishimura, R. A. AU - Holmes, D. R. AU - Lerman, A. PY - 2000 DA - 2000// TI - Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction JO - Circulation VL - 101 UR - https://doi.org/10.1161/01.CIR.101.9.948 DO - 10.1161/01.CIR.101.9.948 ID - Suwaidi2000 ER - TY - JOUR AU - Elming, H. AU - Holm, E. AU - Jun, L. AU - Torp-Pedersen, C. AU - Kober, L. AU - Kircshoff, M. AU - Malik, M. AU - Camm, J. PY - 1998 DA - 1998// TI - The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens JO - Eur Heart J VL - 19 UR - https://doi.org/10.1053/euhj.1998.1094 DO - 10.1053/euhj.1998.1094 ID - Elming1998 ER - TY - JOUR AU - Nolan, J. AU - Batin, P. D. AU - Andrews, R. AU - Lindsay, S. J. AU - Brooksby, P. AU - Mullen, M. AU - Baig, W. AU - Flapan, A. D. AU - Cowley, A. AU - Prescott, R. J. AU - Neilson, J. M. AU - Fox, K. A. PY - 1998 DA - 1998// TI - Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart) JO - Circulation VL - 98 UR - https://doi.org/10.1161/01.CIR.98.15.1510 DO - 10.1161/01.CIR.98.15.1510 ID - Nolan1998 ER - TY - JOUR AU - Pitt, B. AU - Zannad, F. AU - Remme, W. J. AU - Cody, R. AU - Castaigne, A. AU - Perez, A. AU - Palensky, J. AU - Wittes, J. PY - 1999 DA - 1999// TI - The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199909023411001 DO - 10.1056/NEJM199909023411001 ID - Pitt1999 ER - TY - JOUR AU - Yee, K. M. AU - Pringle, S. D. AU - Struthers, A. D. PY - 2001 DA - 2001// TI - Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure JO - J Am Coll Cardiol VL - 37 UR - https://doi.org/10.1016/S0735-1097(01)01243-8 DO - 10.1016/S0735-1097(01)01243-8 ID - Yee2001 ER - TY - JOUR AU - Farquharson, C. A. AU - Struthers, A. D. PY - 2000 DA - 2000// TI - Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure JO - Circulation VL - 101 UR - https://doi.org/10.1161/01.CIR.101.6.594 DO - 10.1161/01.CIR.101.6.594 ID - Farquharson2000 ER - TY - JOUR AU - Lim, P. O. AU - Donnan, P. T. AU - MacDonald, T. M. PY - 2001 DA - 2001// TI - Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients JO - J Hum Hypertens VL - 15 UR - https://doi.org/10.1038/sj.jhh.1001138 DO - 10.1038/sj.jhh.1001138 ID - Lim2001 ER - TY - JOUR AU - Zannad, F. AU - Alla, F. AU - Dousset, B. AU - Perez, A. AU - Pitt, B. PY - 2000 DA - 2000// TI - Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.22.2700 DO - 10.1161/01.CIR.102.22.2700 ID - Zannad2000 ER - TY - JOUR AU - Flack, J. M. AU - Peters, R. AU - Shafi, T. AU - Alrefai, H. AU - Nasser, S. A. AU - Crook, E. PY - 2003 DA - 2003// TI - Prevention of hypertension and its complications: theoretical basis and guidelines for treatment JO - J Am Soc Nephrol VL - 14 UR - https://doi.org/10.1097/01.ASN.0000070142.14843.8E DO - 10.1097/01.ASN.0000070142.14843.8E ID - Flack2003 ER - TY - JOUR AU - Gandhi, S. AU - Santiesteban, H. PY - 1996 DA - 1996// TI - Resistant hypertension. Suggestions for dealing with the problem JO - Postgrad Med VL - 100 UR - https://doi.org/10.3810/pgm.1996.10.94 DO - 10.3810/pgm.1996.10.94 ID - Gandhi1996 ER - TY - JOUR AU - Gordon, R. D. AU - Stowasser, M. AU - Tunny, T. J. AU - Klemm, S. A. AU - Rutherford, J. C. PY - 1994 DA - 1994// TI - High incidence of primary aldosteronism in 199 patients referred with hypertension JO - Clin Exp Pharmacol Physiol VL - 21 UR - https://doi.org/10.1111/j.1440-1681.1994.tb02519.x DO - 10.1111/j.1440-1681.1994.tb02519.x ID - Gordon1994 ER - TY - JOUR AU - Isles, C. G. AU - Walker, L. M. AU - Beevers, G. D. AU - Brown, I. AU - Cameron, H. L. AU - Clarke, J. AU - Hawthorne, V. AU - Hole, D. AU - Lever, A. F. AU - Robertson, J. W. PY - 1986 DA - 1986// TI - Mortality in patients of the Glasgow Blood Pressure Clinic JO - J Hypertens VL - 4 UR - https://doi.org/10.1097/00004872-198604000-00003 DO - 10.1097/00004872-198604000-00003 ID - Isles1986 ER - TY - JOUR AU - Struthers, A. D. PY - 2002 DA - 2002// TI - Aldosterone: cardiovascular assault JO - Am Heart J VL - 144 UR - https://doi.org/10.1067/mhj.2002.129969 DO - 10.1067/mhj.2002.129969 ID - Struthers2002 ER - TY - JOUR AU - Brilla, C. G. AU - Matsubara, L. S. AU - Weber, K. T. PY - 1993 DA - 1993// TI - Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism JO - J Mol Cell Cardiol VL - 25 UR - https://doi.org/10.1006/jmcc.1993.1066 DO - 10.1006/jmcc.1993.1066 ID - Brilla1993 ER - TY - JOUR AU - Sato, A. AU - Funder, J. W. AU - Saruta, T. PY - 1999 DA - 1999// TI - Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis JO - Am J Hypertens VL - 12 UR - https://doi.org/10.1016/S0895-7061(99)00066-7 DO - 10.1016/S0895-7061(99)00066-7 ID - Sato1999 ER - TY - JOUR AU - Pitt, B. AU - Remme, W. AU - Zannad, F. AU - Neaton, J. AU - Martinez, F. AU - Roniker, B. AU - Bittman, R. AU - Hurley, S. AU - Kleiman, J. AU - Gatlin, M. PY - 2003 DA - 2003// TI - Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa030207 DO - 10.1056/NEJMoa030207 ID - Pitt2003 ER - TY - JOUR AU - Farquharson, C. A. AU - Struthers, A. D. PY - 2002 DA - 2002// TI - Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy JO - Clin Sci (Lond) VL - 103 UR - https://doi.org/10.1042/cs1030425 DO - 10.1042/cs1030425 ID - Farquharson2002 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/7/14/prepub UR - http://www.biomedcentral.com/1471-2261/7/14/prepub ID - ref36 ER -